[Clinical value of portable sleep testing in children with obstructive sleep apnea syndrome]

Miaoshang Su1, Chenyi Yu1, Yuanbo Zhang1

  • 1Department of Pediatric Respiratory Medicine, the Second Affiliated Hospital & Yuying Children's Hospital, Wenzhou Medical University, Wenzhou 325027, China.

Insights

Portable sleep testing (PAT) shows high consistency with polysomnography (PSG) for diagnosing obstructive sleep apnea syndrome (OSAS) in school-aged children. This makes PAT a reliable home-based diagnostic tool for pediatric OSAS.

Area of Science:

  • Pediatric Sleep Medicine
  • Respiratory Medicine
  • Diagnostic Technologies

Background:

  • Obstructive sleep apnea syndrome (OSAS) is a prevalent condition in children.
  • Accurate diagnosis of pediatric OSAS is crucial for timely intervention and management.
  • Polysomnography (PSG) is the gold standard but can be resource-intensive.

Purpose of the Study:

  • To evaluate the clinical utility of the Watch-PAT (PAT) portable sleep monitor for diagnosing OSAS in children.
  • To compare the diagnostic performance of PAT with PSG in a pediatric population.
  • To assess the feasibility of home-based sleep testing using PAT.

Main Methods:

  • A cohort of 50 snoring children aged 3-11 years underwent simultaneous PSG and PAT.
  • Sleep parameters obtained from both devices were compared for consistency.
  • Receiver Operating Characteristic (ROC) curve analysis was used to determine PAT's diagnostic accuracy for OSAS.

Main Results:

  • PAT demonstrated high consistency with PSG in diagnosing OSAS in school-aged children (6-11 years).
  • Significant differences were observed between PAT and PSG in younger children (3-5 years).
  • ROC analysis indicated high sensitivity and specificity for PAT in detecting OSAS, particularly at higher Apnea-Hypopnea Index (AHI) thresholds.

Conclusions:

  • The Watch-PAT device is a viable and consistent tool for diagnosing OSAS in school-aged children.
  • High compliance and consistency with PSG support the use of PAT for home-based testing in this age group.
  • Further validation may be needed for very young children (3-5 years).
Abstract